Evidence map›Paper›PMID 34524690›Full record

ArticleJournal of medical virology2022

Assessment of two-pool multiplex long-amplicon nanopore sequencing of SARS-CoV-2.

Hongjie Liu, Jinhui Li, Yanfeng Lin, Xiaochen Bo, Hongbin Song, Kuibiao Li, Peng Li, Ming Ni

Open access · greenAbstract read
In one paragraph

Article in Journal of medical virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Hongjie LiuDepartment of Biotechnology, Beijing Institute of Radiation Medicine, Beijing, China.
Jinhui LiDepartment of Bio-security, Chinese PLA Center for Disease Control and Prevention, Beijing, China.
Yanfeng LinDepartment of Bio-security, Chinese PLA Center for Disease Control and Prevention, Beijing, China.
Xiaochen BoDepartment of Biotechnology, Beijing Institute of Radiation Medicine, Beijing, China.
Hongbin SongDepartment of Bio-security, Chinese PLA Center for Disease Control and Prevention, Beijing, China.
Kuibiao LiLaboratory of Clinical Microbiology, Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, China.
Peng LiDepartment of Bio-security, Chinese PLA Center for Disease Control and Prevention, Beijing, China.
Ming NiDepartment of Biotechnology, Beijing Institute of Radiation Medicine, Beijing, China.ORCID 0000-0001-9465-2787
Chinese Center For Disease Control and Prevention · CNBeijing Radiation Center · CNGuangzhou Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) plays an important role in COVID-19 pandemic control and elimination efforts, especially by elucidating its global transmission network and illustrating its viral evolution. The deployment of multiplex PCR assays that target SARS-CoV-2 followed by either massively parallel or nanopore sequencing is a widely-used strategy to obtain genome sequences from primary samples. However, multiplex PCR-based sequencing carries an inherent bias of sequencing depth among different amplicons, which may cause uneven coverage. Here we developed a two-pool, long-amplicon 36-plex PCR primer panel with ~1000-bp amplicon lengths for full-genome sequencing of SARS-CoV-2. We validated the panel by assessing nasopharyngeal swab samples with a <30 quantitative reverse transcription PCR cycle threshold value and found that ≥90% of viral genomes could be covered with high sequencing depths (≥20% mean depth). In comparison, the widely-used ARTIC panel yielded 79%-88% high-depth genome regions. We estimated that ~5 Mbp nanopore sequencing data may ensure a >95% viral genome coverage with a ≥10-fold depth and may generate reliable genomes at consensus sequence levels. Nanopore sequencing yielded false-positive variations with frequencies of supporting reads <0.8, and the sequencing errors mostly occurred on the 5' or 3' ends of reads. Thus, nanopore sequencing could not elucidate intra-host viral diversity.

Indexed as

COVID-19Genome, ViralHigh-Throughput Nucleotide SequencingHumansMultiplex Polymerase Chain ReactionNanopore SequencingNasopharynxRNA, ViralSARS-CoV-2Sequence Analysis, RNAWhole Genome SequencingRNA, Viralgenomemultiplex polymerase chain reactionnanopore sequencingSARS-CoV-2viral

Identifiers

PMID34524690
PMCPMC8662006
OpenAlexW3199047268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.